Found: 61
Select item for more details and to access through your institution.
The prevalence of laboratory-confirmed Pneumocystis jirovecii in HIV-infected adults in Africa: A systematic review and meta-analysis.
- Published in:
- Medical Mycology, 2021, v. 59, n. 8, p. 802, doi. 10.1093/mmy/myab002
- By:
- Publication type:
- Article
The Impact of GeneXpert Cerebrospinal Fluid Testing on Tuberculous Meningitis Diagnosis in Routine Care in Botswana.
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 9, p. 1, doi. 10.1093/ofid/ofae489
- By:
- Publication type:
- Article
Clinical Outcomes of US Adults Hospitalized for COVID-19 and Influenza in the Respiratory Virus Hospitalization Surveillance Network, October 2021–September 2022.
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 1, p. 1, doi. 10.1093/ofid/ofad702
- By:
- Publication type:
- Article
Effectiveness of the Original Monovalent Coronavirus Disease 2019 Vaccines in Preventing Emergency Department or Urgent Care Encounters and Hospitalizations Among Adults With Disabilities: VISION Network, June 2021-September 2022.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 11, p. 1, doi. 10.1093/ofid/ofad474
- By:
- Publication type:
- Article
Influenza Antiviral Use in Patients Hospitalized With Laboratory-Confirmed Influenza in the United States, FluSurv-NET, 2015–2019.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 1, p. 1, doi. 10.1093/ofid/ofac681
- By:
- Publication type:
- Article
Human Herpesvirus-6 Detection in Cerebrospinal Fluid on the BioFire FilmArray Meningitis/Encephalitis Panel in a High Human Immunodeficiency Virus-Prevalence African Setting.
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 7, p. 1, doi. 10.1093/ofid/ofac229
- By:
- Publication type:
- Article
High Mortality in HIV-Associated Cryptococcal Meningitis Patients Treated With Amphotericin B–Based Therapy Under Routine Care Conditions in Africa.
- Published in:
- Open Forum Infectious Diseases, 2018, v. 5, n. 11, p. N.PAG, doi. 10.1093/ofid/ofy267
- By:
- Publication type:
- Article
Maternal Hepatitis B Infection and Pregnancy Outcomes in the United States: A Population-Based Cohort Study.
- Published in:
- Open Forum Infectious Diseases, 2018, v. 5, n. 6, p. N.PAG, doi. 10.1093/ofid/ofy134
- By:
- Publication type:
- Article
Neurological Sequelae of Adult Meningitis in Africa: A Systematic Literature Review.
- Published in:
- Open Forum Infectious Diseases, 2018, v. 5, n. 1, p. N.PAG, doi. 10.1093/ofid/ofx246
- By:
- Publication type:
- Article
Mortality from HIV‐associated meningitis in sub‐Saharan Africa: a systematic review and meta‐analysis.
- Published in:
- Journal of the International AIDS Society, 2020, v. 23, n. 1, p. N.PAG, doi. 10.1002/jia2.25416
- By:
- Publication type:
- Article
Interim Influenza Vaccine Effectiveness Against Laboratory-Confirmed Influenza--California, October 2023-January 2024.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2024, v. 73, n. 8, p. 175, doi. 10.15585/mmwr.mm7308a4
- By:
- Publication type:
- Article
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults -- VISION Network, Nine States, September-November 2022.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2022, v. 71, n. 51/52, p. 1616, doi. 10.15585/mmwr.mm715152e1
- By:
- Publication type:
- Article
Effectiveness of mRNA Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death - United States, March 2021-January 2022.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2022, v. 71, n. 12, p. 459
- By:
- Publication type:
- Article
Effectiveness of a Third Dose of Pfizer-BioNTech and Moderna Vaccines in Preventing COVID-19 Hospitalization Among Immunocompetent and Immunocompromised Adults -- United States, August-December 2021.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2022, v. 71, n. 4, p. 118
- By:
- Publication type:
- Article
Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions -- United States, March-August 2021.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2021, v. 70, n. 38, p. 1337, doi. 10.15585/mmwr.mm7038e1
- By:
- Publication type:
- Article
Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults - United States, March-July 2021.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years - United States, January-March 2021.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Telework Before Illness Onset Among Symptomatic Adults Aged ≥18 Years With and Without COVID-19 in 11 Outpatient Health Care Facilities - United States, July 2020.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2020, v. 69, n. 44, p. 1648, doi. 10.15585/mmwr.mm6944a4
- By:
- Publication type:
- Article
Community and Close Contact Exposures Associated with COVID-19 Among Symptomatic Adults ≥18 Years in 11 Outpatient Health Care Facilities - United States, July 2020.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Seroprevalence of SARS-CoV-2 Among Frontline Health Care Personnel in a Multistate Hospital Network - 13 Academic Medical Centers, April-June 2020.
- Published in:
- 2020
- By:
- Publication type:
- journal article
C-Reactive Protein (CRP), Interferon Gamma-Inducible Protein 10 (IP-10), and Lipopolysaccharide (LPS) Are Associated with Risk of Tuberculosis after Initiation of Antiretroviral Therapy in Resource-Limited Settings.
- Published in:
- PLoS ONE, 2015, v. 10, n. 2, p. 1, doi. 10.1371/journal.pone.0117424
- By:
- Publication type:
- Article
Modeling clinical trajectory status of critically ill COVID-19 patients over time: A method for analyzing discrete longitudinal and ordinal outcomes.
- Published in:
- Journal of Clinical & Translational Science, 2022, v. 6, n. 1, p. 1, doi. 10.1017/cts.2022.393
- By:
- Publication type:
- Article
Communicating the Value of Influenza Vaccines to Patients.
- Published in:
- Annals of Internal Medicine, 2024, v. 177, n. 7, p. 991, doi. 10.7326/L24-0142
- By:
- Publication type:
- Article
Communicating the Value of Influenza Vaccines to Patients: Translating Vaccine Effectiveness to Acceptance.
- Published in:
- Annals of Internal Medicine, 2023, v. 176, n. 12, p. 1670, doi. 10.7326/M23-2802
- By:
- Publication type:
- Article
Differentiating severe and non-severe lower respiratory tract illness in patients hospitalized with influenza: Development of the Influenza Disease Evaluation and Assessment of Severity (IDEAS) scale.
- Published in:
- PLoS ONE, 2021, v. 16, n. 10, p. 1, doi. 10.1371/journal.pone.0258482
- By:
- Publication type:
- Article
Clinical Influenza Testing Practices in Hospitalized Children at United States Medical Centers, 2015-2018.
- Published in:
- Journal of the Pediatric Infectious Diseases Society, 2022, v. 11, n. 1, p. 5, doi. 10.1093/jpids/piab096
- By:
- Publication type:
- Article
Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines for Preventing Coronavirus Disease 2019 Hospitalizations in the United States.
- Published in:
- Clinical Infectious Diseases, 2022, v. 74, n. 9, p. 1515, doi. 10.1093/cid/ciab687
- By:
- Publication type:
- Article
Effect of Antigenic Drift on Influenza Vaccine Effectiveness in the United States—2019–2020.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 11, p. e4244, doi. 10.1093/cid/ciaa1884
- By:
- Publication type:
- Article
Influenza Vaccine Effectiveness in Inpatient and Outpatient Settings in the United States, 2015–2018.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 3, p. 386, doi. 10.1093/cid/ciaa407
- By:
- Publication type:
- Article
Adults Hospitalized With Coronavirus Disease 2019 (COVID-19)—United States, March–June and October–December 2020: Implications for the Potential Effects of COVID-19 Tier-1 Vaccination on Future Hospitalizations and Outcomes.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, p. S32, doi. 10.1093/cid/ciab319
- By:
- Publication type:
- Article
Prevalence and Sequelae of Cryptococcal Antigenemia in Antiretroviral Therapy–Experienced Populations: An Evaluation of Reflex Cryptococcal Antigen Screening in Botswana.
- Published in:
- Clinical Infectious Diseases, 2021, v. 72, n. 10, p. 1745, doi. 10.1093/cid/ciaa356
- By:
- Publication type:
- Article
Outcomes of Reflex Cryptococcal Antigen (CrAg) Screening in Human Immunodeficiency Virus (HIV)-Positive Patients With CD4 Counts of 100–200 Cells/µL in Botswana.
- Published in:
- Clinical Infectious Diseases, 2021, v. 72, n. 9, p. 1635, doi. 10.1093/cid/ciaa899
- By:
- Publication type:
- Article
Seroprevalence of SARS-CoV-2 Among Frontline Healthcare Personnel During the First Month of Caring for Patients With COVID-19—Nashville, Tennessee.
- Published in:
- Clinical Infectious Diseases, 2021, v. 72, n. 9, p. 1645, doi. 10.1093/cid/ciaa936
- By:
- Publication type:
- Article
Reduction in Baseline CD4 Count Testing Following Human Immunodeficiency Virus "Treat All" Adoption in Uganda.
- Published in:
- Clinical Infectious Diseases, 2020, v. 71, n. 9, p. 2497, doi. 10.1093/cid/ciaa261
- By:
- Publication type:
- Article
Short-course High-dose Liposomal Amphotericin B for Human Immunodeficiency Virus–associated Cryptococcal Meningitis: A Phase 2 Randomized Controlled Trial.
- Published in:
- Clinical Infectious Diseases, 2019, v. 68, n. 3, p. 393, doi. 10.1093/cid/ciy515
- By:
- Publication type:
- Article
Advanced Human Immunodeficiency Virus Disease in Botswana Following Successful Antiretroviral Therapy Rollout: Incidence of and Temporal Trends in Cryptococcal Meningitis.
- Published in:
- Clinical Infectious Diseases, 2017, v. 65, n. 5, p. 779, doi. 10.1093/cid/cix430
- By:
- Publication type:
- Article
An updated systematic review of HIV‐associated cryptococcal meningitis treatment strategies.
- Published in:
- HIV Medicine, 2023, v. 24, n. 4, p. 507, doi. 10.1111/hiv.13412
- By:
- Publication type:
- Article
Long-term Protection Associated With COVID-19 Vaccination and Prior Infection.
- Published in:
- JAMA: Journal of the American Medical Association, 2022, v. 328, n. 14, p. 1402, doi. 10.1001/jama.2022.14660
- By:
- Publication type:
- Article
Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity.
- Published in:
- JAMA: Journal of the American Medical Association, 2021, v. 326, n. 20, p. 2043, doi. 10.1001/jama.2021.19499
- By:
- Publication type:
- Article
Identifying COVID-19 Risk Through Observational Studies to Inform Control Measures.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Tracking Cryptococcal Meningitis to Monitor HIV Program Success During the Treat All Era: An Analysis of National Data in Botswana.
- Published in:
- Clinical Infectious Diseases, 2024, v. 79, n. 2, p. 462, doi. 10.1093/cid/ciae066
- By:
- Publication type:
- Article
Vaccine Effectiveness Against Influenza A(H3N2)–Associated Hospitalized Illness: United States, 2022.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 6, p. 1030, doi. 10.1093/cid/ciac869
- By:
- Publication type:
- Article
Protection of Messenger RNA Vaccines Against Hospitalized Coronavirus Disease 2019 in Adults Over the First Year Following Authorization in the United States.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 3, p. e460, doi. 10.1093/cid/ciac381
- By:
- Publication type:
- Article
Immune correlates of HIV-associated cryptococcal meningitis.
- Published in:
- PLoS Pathogens, 2017, v. 13, n. 3, p. 1, doi. 10.1371/journal.ppat.1006207
- By:
- Publication type:
- Article
Effectiveness of two and three mRNA COVID‐19 vaccine doses against Omicron‐ and Delta‐Related outpatient illness among adults, October 2021–February 2022.
- Published in:
- Influenza & Other Respiratory Viruses, 2022, v. 16, n. 6, p. 975, doi. 10.1111/irv.13029
- By:
- Publication type:
- Article
Associations between persistent symptoms after mild COVID‐19 and long‐term health status, quality of life, and psychological distress.
- Published in:
- Influenza & Other Respiratory Viruses, 2022, v. 16, n. 4, p. 680, doi. 10.1111/irv.12980
- By:
- Publication type:
- Article
Symptoms and recovery among adult outpatients with and without COVID‐19 at 11 healthcare facilities—July 2020, United States.
- Published in:
- Influenza & Other Respiratory Viruses, 2021, v. 15, n. 3, p. 345, doi. 10.1111/irv.12832
- By:
- Publication type:
- Article
Exposures in adult outpatients with COVID‐19 infection during early community transmission, Tennessee.
- Published in:
- Influenza & Other Respiratory Viruses, 2021, v. 15, n. 1, p. 175, doi. 10.1111/irv.12792
- By:
- Publication type:
- Article
Rapid antiretroviral therapy initiation in low- and middle-income countries: A resource-based approach.
- Published in:
- 2019
- By:
- Publication type:
- journal article